Connor, Clark & Lunn Investment Management Ltd. Organon & Co. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$13.78 - $18.8 $3.92 Million - $5.35 Million	-284,509 Reduced 88.64%	36,477 $685,000
Q4 2023 Feb 09, 2024	BUY	$10.95 - $17.32 $3.38 Million - $5.35 Million	309,063 Added 2592.16%	320,986 $4.63 Million
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $197,802 - $283,409	11,923 New	11,923 $206,000

Others Institutions Holding OGN

# of Institutions

790

Shares Held

204M

Call Options Held

1.71M

Put Options Held

870K

Black Rock Inc. New York, NY

32.6M
Shares

$486 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

30.2M
Shares

$450 Million
0.01% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.2M
Shares

$166 Million
0.41% of portfolio
Massachusetts Financial Services CO Boston, MA

9.76M
Shares

$145 Million
0.06% of portfolio
State Street Corp Boston, MA

8.98M
Shares

$134 Million
0.01% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account